Anthem Biosciences Announcements
Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended Marcg 31, 2026
06 Apr, 2026 | 06:39pm • Source: BSE
Closure of Trading Window for the quarter and year ended March 31, 2026
27 Mar, 2026 | 03:05pm • Source: BSE
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2025, we hereby inform that the Company has executed on February 23, 2026,...
23 Feb, 2026 | 07:17pm • Source: BSE
Earnings Call Transcript for Q3 FY26
09 Feb, 2026 | 04:31pm • Source: BSE
Newspaper Publication of Financial Results for the quarter and nine months ended December 31, 2025
06 Feb, 2026 | 12:37pm • Source: BSE
Submission of audio recordings of Earnings Call for the quarter and nine months ended December 31, 2025
05 Feb, 2026 | 06:03pm • Source: BSE
Allotment of 1,03,800 equity shares, of face value Rs. 2 each, pursuant to the exercise of ESOP Options under Anthem Employee Stock Option Plan 2024
05 Feb, 2026 | 02:30pm • Source: BSE
Submission of revised Press Release for the Financial Results for the quarter and nine months ended December 31, 2025 due to inadvertent missing on the...
05 Feb, 2026 | 02:26pm • Source: BSE
Press release for the financial results for the quarter and nine months ended December 31, 2025
05 Feb, 2026 | 01:48pm • Source: BSE
Submission of Investor Presentation for the quarter and nine months ended December 31, 2025
05 Feb, 2026 | 01:33pm • Source: BSE
Submission of financial results for the quarter and nine months ended December 31, 2025
05 Feb, 2026 | 01:25pm • Source: BSE
Submission of Unaudited Standalone and Consolidated Financial Results with Limited Review Report of Statutory Auditors for the quarter and nine months ended December 31, 2025
05 Feb, 2026 | 01:14pm • Source: BSE
Revised Earnings Conference Call to discuss the unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2025
27 Jan, 2026 | 10:18pm • Source: BSE
Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish...
27 Jan, 2026 | 05:46pm • Source: BSE
Anthem Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2026 ,inter alia, to consider and...
27 Jan, 2026 | 05:37pm • Source: BSE
Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018
07 Jan, 2026 | 04:26pm • Source: BSE
Issuance of Corporate Guarantee in favor of Citi Bank N.A and Federal Bank Limited amounting to Rs. 25 Crores and 24 Crores Respectively on behalf...
07 Jan, 2026 | 02:18pm • Source: BSE
Closure of Trading Window for consideration of Financial Results for the quarter ended December 31, 2025
29 Dec, 2025 | 04:21pm • Source: BSE
Intimation for Schedule of Analyst/Investor Meet
15 Dec, 2025 | 03:06pm • Source: BSE
Earnings Call Transcript for the financial result of quarter and half year ended September 30, 2025
12 Nov, 2025 | 06:19pm • Source: BSE